首页 > 最新文献

中国疾病预防控制中心周报最新文献

英文 中文
Reported Cases and Deaths of National Notifiable Infectious Diseases - China, September 2024. 中国2024年9月国家法定传染病报告病例和死亡人数
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-13 DOI: 10.46234/ccdcw2024.266
{"title":"Reported Cases and Deaths of National Notifiable Infectious Diseases - China, September 2024.","authors":"","doi":"10.46234/ccdcw2024.266","DOIUrl":"https://doi.org/10.46234/ccdcw2024.266","url":null,"abstract":"","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 50","pages":"1343-1344"},"PeriodicalIF":4.3,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance for Adverse Events Following Immunization with Domestic Sabin-Strain Inactivated Poliovirus Vaccine - China, 2015-2022. 2015-2022 年中国对接种国产 Sabin 株脊髓灰质炎病毒灭活疫苗后不良反应的监测。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-13 DOI: 10.46234/ccdcw2024.261
Chunxiang Fan, Keli Li, Lina Zhang, Yuan Li, Yifan Song, Yan Li, Minrui Ren, Lance E Rodewald, Zundong Yin

Introduction: Domestic Sabin-strain inactivated poliovirus vaccine (sIPV) was approved for use in China in 2015 and introduced into the national immunization schedule in a sequential schedule with oral poliovirus vaccine (OPV) in May 2016. However, a comprehensive analysis describing the characteristics, occurrences, and incidences of adverse events following immunization (AEFI) with sIPV in China is lacking.

Methods: Data on sIPV doses administered and AEFI reported from 2015 to 2022 were obtained from the Chinese National Immunization Information System (CNIIS). Descriptive epidemiological methods and statistics were used to analyze and describe the characteristics, occurrences, and incidences of AEFI following sIPV in China from 2015 to 2022.

Results: From 2015 to 2022, over 110,000,000 sIPV doses were administered, and 46,748 sIPV AEFIs were reported, resulting in an AEFI reporting rate of 42.44/100,000. Most AEFIs (46,333, 99.11%) were non-serious. Causality assessment determined 46,061 (98.53%) AEFIs were vaccine product-related reactions, including 44,001 (94.12%) common and 2,060 (4.41%) rare vaccine reactions. Among common vaccine reactions, reporting rates for fever >38.5 °C, local redness and swelling ≥2.6 cm, and local induration ≥2.6 cm were 12.02/100,000, 5.13/100,000, and 1.67/100,000, respectively. Among rare vaccine reactions, reporting rates for anaphylactic rash, thrombocytopenic purpura, and febrile convulsion were 1.56/100,000, 0.09/100,000, and 0.03/100,000, respectively.

Conclusions: Most reported sIPV AEFIs were non-serious, and the reporting rate of rare vaccine reactions has been very low since sIPV was approved for use in China. As sIPV remains in use in China, surveillance of AEFIs associated with this vaccine needs to be maintained.

简介:国产sabin株脊髓灰质炎灭活疫苗(sIPV)于2015年在中国获批使用,并于2016年5月与口服脊髓灰质炎病毒疫苗(OPV)先后纳入国家免疫规划。然而,中国缺乏描述sIPV免疫接种后不良事件(AEFI)特征、发生情况和发生率的综合分析。方法:从中国国家免疫信息系统(CNIIS)获取2015 - 2022年sIPV给药剂量和AEFI数据。采用描述性流行病学方法和统计学方法,分析和描述2015 - 2022年中国sIPV后AEFI的特征、发生情况和发病率。结果:2015 - 2022年,sIPV接种量超过1.1亿剂,报告sIPV AEFI 46748例,AEFI报告率为42.44/10万。大多数急性脑损伤患者(46,333例,占99.11%)不严重。因果关系评估确定46061例(98.53%)aefi为疫苗产品相关反应,其中4401例(94.12%)为常见反应,2060例(4.41%)为罕见反应。在常见的疫苗反应中,发热低于38.5°C、局部红肿≥2.6 cm、局部硬化≥2.6 cm的报告率分别为12.02/10万、5.13/10万、1.67/10万。在罕见的疫苗反应中,过敏性皮疹、血小板减少性紫癜和热性惊厥的报告率分别为1.56/10万、0.09/10万和0.03/10万。结论:自sIPV在中国被批准使用以来,大多数报告的sIPV不良反应不严重,罕见疫苗反应的报告率很低。由于sIPV在中国仍在使用,因此需要继续监测与该疫苗相关的aefi。
{"title":"Surveillance for Adverse Events Following Immunization with Domestic Sabin-Strain Inactivated Poliovirus Vaccine - China, 2015-2022.","authors":"Chunxiang Fan, Keli Li, Lina Zhang, Yuan Li, Yifan Song, Yan Li, Minrui Ren, Lance E Rodewald, Zundong Yin","doi":"10.46234/ccdcw2024.261","DOIUrl":"10.46234/ccdcw2024.261","url":null,"abstract":"<p><strong>Introduction: </strong>Domestic Sabin-strain inactivated poliovirus vaccine (sIPV) was approved for use in China in 2015 and introduced into the national immunization schedule in a sequential schedule with oral poliovirus vaccine (OPV) in May 2016. However, a comprehensive analysis describing the characteristics, occurrences, and incidences of adverse events following immunization (AEFI) with sIPV in China is lacking.</p><p><strong>Methods: </strong>Data on sIPV doses administered and AEFI reported from 2015 to 2022 were obtained from the Chinese National Immunization Information System (CNIIS). Descriptive epidemiological methods and statistics were used to analyze and describe the characteristics, occurrences, and incidences of AEFI following sIPV in China from 2015 to 2022.</p><p><strong>Results: </strong>From 2015 to 2022, over 110,000,000 sIPV doses were administered, and 46,748 sIPV AEFIs were reported, resulting in an AEFI reporting rate of 42.44/100,000. Most AEFIs (46,333, 99.11%) were non-serious. Causality assessment determined 46,061 (98.53%) AEFIs were vaccine product-related reactions, including 44,001 (94.12%) common and 2,060 (4.41%) rare vaccine reactions. Among common vaccine reactions, reporting rates for fever >38.5 °C, local redness and swelling ≥2.6 cm, and local induration ≥2.6 cm were 12.02/100,000, 5.13/100,000, and 1.67/100,000, respectively. Among rare vaccine reactions, reporting rates for anaphylactic rash, thrombocytopenic purpura, and febrile convulsion were 1.56/100,000, 0.09/100,000, and 0.03/100,000, respectively.</p><p><strong>Conclusions: </strong>Most reported sIPV AEFIs were non-serious, and the reporting rate of rare vaccine reactions has been very low since sIPV was approved for use in China. As sIPV remains in use in China, surveillance of AEFIs associated with this vaccine needs to be maintained.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 50","pages":"1313-1318"},"PeriodicalIF":4.3,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunogenicity of Short-Course, High-Dose Hepatitis B Vaccination in Patients with Chronic Kidney Disease - Shanxi Province, China, 2019-2020. 慢性肾脏疾病患者短疗程高剂量乙型肝炎疫苗免疫原性研究——山西省,中国,2019-2020。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-13 DOI: 10.46234/ccdcw2024.264
Linying Gao, Xufeng Cui, Xinyuan Mo, Zhaoyue Men, Xiuyang Xu, Tian Yao, Jianmin Wang, Hongting Liu, Hongping Guo, Guowei Chai, Liming Liu, Fuzhen Wang, Xiaofeng Liang, Suping Wang, Yongliang Feng

What is already known about this topic?: As one of the populations at high risk of hepatitis B virus (HBV) infection, patients with chronic kidney disease (CKD) require rapid and effective development of hepatitis B surface antibodies (anti-HBs).

What is added by this report?: The short-course, high-dose regimen of hepatitis B vaccination rapidly induced comparable immunological responses to the routine regimen, achieving a seroconversion rate of 88.5%, a high-response rate of 64.1%, and anti-HBs geometric mean concentrations of 824.1 mIU/mL.

What are the implications for public health practice?: The short-course, high-dose regimen represents an effective rapid immunization strategy for CKD patients, particularly when administered prior to immunosuppressive therapy. This study provides compelling evidence for optimizing immunization protocols in the CKD population.

本主题的已知信息:作为乙型肝炎病毒(HBV)感染的高危人群之一,慢性肾脏病(CKD)患者需要快速有效地发展乙型肝炎表面抗体(抗-HBs):短程大剂量乙肝疫苗接种方案能迅速诱导出与常规方案相当的免疫反应,实现了88.5%的血清转换率、64.1%的高应答率和824.1 mIU/mL的抗-HBs几何平均浓度:短程、大剂量方案是针对慢性肾脏病患者的一种有效的快速免疫策略,尤其是在免疫抑制治疗前进行免疫接种时。这项研究为优化 CKD 患者的免疫方案提供了令人信服的证据。
{"title":"Immunogenicity of Short-Course, High-Dose Hepatitis B Vaccination in Patients with Chronic Kidney Disease - Shanxi Province, China, 2019-2020.","authors":"Linying Gao, Xufeng Cui, Xinyuan Mo, Zhaoyue Men, Xiuyang Xu, Tian Yao, Jianmin Wang, Hongting Liu, Hongping Guo, Guowei Chai, Liming Liu, Fuzhen Wang, Xiaofeng Liang, Suping Wang, Yongliang Feng","doi":"10.46234/ccdcw2024.264","DOIUrl":"10.46234/ccdcw2024.264","url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>As one of the populations at high risk of hepatitis B virus (HBV) infection, patients with chronic kidney disease (CKD) require rapid and effective development of hepatitis B surface antibodies (anti-HBs).</p><p><strong>What is added by this report?: </strong>The short-course, high-dose regimen of hepatitis B vaccination rapidly induced comparable immunological responses to the routine regimen, achieving a seroconversion rate of 88.5%, a high-response rate of 64.1%, and anti-HBs geometric mean concentrations of 824.1 mIU/mL.</p><p><strong>What are the implications for public health practice?: </strong>The short-course, high-dose regimen represents an effective rapid immunization strategy for CKD patients, particularly when administered prior to immunosuppressive therapy. This study provides compelling evidence for optimizing immunization protocols in the CKD population.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 50","pages":"1331-1336"},"PeriodicalIF":4.3,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction of a Competency Evaluation Indicator System for Emergency Response Staff in Disease Control and Prevention Institutions - China, 2023. 疾病预防控制机构应急人员能力评价指标体系构建——中国,2023。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-06 DOI: 10.46234/ccdcw2024.260
Zhaohe Li, Xijiang Wang, Wenqing Bai, Haoliang Liu, Yue Gu, Jiayi Zhang, Huimin Li, Hongtao Wu, Ruiqi Ren, Chao Li, Qi Wang, Zainawudong Yushan, Lei Zhou

What is already known about this topic?: Currently, there is no established scientific standard to guide disease control and prevention organizations in the selection of emergency response personnel. Given the growing risk of significant infectious disease outbreaks, it is imperative to develop an evaluation system for assessing emergency response capabilities.

What is added by this report?: Drawing from competency theory, this study developed an assessment framework for evaluating the emergency response capabilities of staff at disease control and prevention institutions focused on major infectious diseases. Utilizing the Delphi method, the framework comprises 4 first-level indicators: Knowledge base, Professional skills, Personal qualities, Personality and Motivation. Further, it includes 10 second-level and 46 third-level indicators. The reliability and validity of this evaluation system were examined through a questionnaire survey. The results show that the indicator system has good reliability, acceptable discriminant and convergent validity, and that competency can be evaluated scientifically.

What are the implications for public health practice?: The system provides an efficient tool for selecting and organizing emergency personnel for response tasks, thereby enhancing the CDC staff's capacity for emergency management.

关于这个话题我们已经知道了什么?目前,疾病预防控制机构在应急响应人员的选择上还没有建立起科学的标准来指导。鉴于重大传染病暴发的风险日益增加,必须建立一个评估应急能力的评估系统。这份报告增加了什么内容?根据胜任力理论,本研究开发了一个评估框架,用于评估以重大传染病为重点的疾病控制和预防机构工作人员的应急反应能力。利用德尔菲法,该框架包括4个一级指标:知识基础、专业技能、个人素质、个性和动机。此外,它还包括10个二级指标和46个三级指标。通过问卷调查对评价体系的信度和效度进行了检验。结果表明,该指标体系具有良好的信度、可接受的判别效度和收敛效度,能够对胜任力进行科学的评价。这对公共卫生实践有什么影响?该系统为选择和组织应急人员执行响应任务提供了一个有效的工具,从而提高了疾病预防控制中心工作人员的应急管理能力。
{"title":"Construction of a Competency Evaluation Indicator System for Emergency Response Staff in Disease Control and Prevention Institutions - China, 2023.","authors":"Zhaohe Li, Xijiang Wang, Wenqing Bai, Haoliang Liu, Yue Gu, Jiayi Zhang, Huimin Li, Hongtao Wu, Ruiqi Ren, Chao Li, Qi Wang, Zainawudong Yushan, Lei Zhou","doi":"10.46234/ccdcw2024.260","DOIUrl":"10.46234/ccdcw2024.260","url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>Currently, there is no established scientific standard to guide disease control and prevention organizations in the selection of emergency response personnel. Given the growing risk of significant infectious disease outbreaks, it is imperative to develop an evaluation system for assessing emergency response capabilities.</p><p><strong>What is added by this report?: </strong>Drawing from competency theory, this study developed an assessment framework for evaluating the emergency response capabilities of staff at disease control and prevention institutions focused on major infectious diseases. Utilizing the Delphi method, the framework comprises 4 first-level indicators: <i>Knowledge base, Professional skills, Personal qualities, Personality and Motivation</i>. Further, it includes 10 second-level and 46 third-level indicators. The reliability and validity of this evaluation system were examined through a questionnaire survey. The results show that the indicator system has good reliability, acceptable discriminant and convergent validity, and that competency can be evaluated scientifically.</p><p><strong>What are the implications for public health practice?: </strong>The system provides an efficient tool for selecting and organizing emergency personnel for response tasks, thereby enhancing the CDC staff's capacity for emergency management.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 49","pages":"1306-1312"},"PeriodicalIF":4.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Genetic Loci Associated with PhenoAge Acceleration - Changzhou City, Jiangsu Province, China, 2012-2019. 与表型加速相关的新基因位点——江苏省常州市,2012-2019。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-06 DOI: 10.46234/ccdcw2024.258
Yifan Wang, Yue Jiang, Hui Wang, Shuang Liang, Muhammed Lamin Sambou, Mei Wang, Meiqi Yang, Yakubu Salimata, Feifei Xu, Chenjie Li, Xiao Wang, Junpeng Yang, Meng Zhu, Cheng Wang, Guangfu Jin, Hongxia Ma, Honggang Yi, Hongbing Shen, Juncheng Dai

What is already known about this topic?: China is rapidly encountering population aging, yet studies on aging are limited by the traditional aging measure: chronological age, particularly in the field of genomics. Several promising aging measures have been proposed, but they lack comparative evaluation.

What is added by this report?: PhenoAge was identified as a measure of aging that demonstrated greater applicability in contemporary populations. Based on this, several novel genetic variants were found to enhance the predictive accuracy of aging.

What are the implications for public health practice?: These findings might provide new insights into aging and facilitate the development of a practical screening program based on PhenoAge, which aims to promote healthy aging in China.

关于这个话题我们已经知道了什么?中国正迅速面临人口老龄化问题,但对老龄化问题的研究却受到传统老龄化指标——实足年龄的限制,特别是在基因组学领域。提出了几种有前景的老化措施,但缺乏比较评价。这份报告增加了什么内容?表型年龄(PhenoAge)被认为是一种衡量衰老的指标,在当代人群中表现出更大的适用性。在此基础上,研究人员发现了一些新的基因变异,以提高衰老的预测准确性。这对公共卫生实践有什么影响?这些发现可能为研究衰老提供新的见解,并促进基于PhenoAge的实用筛查项目的发展,旨在促进中国的健康老龄化。
{"title":"Novel Genetic Loci Associated with PhenoAge Acceleration - Changzhou City, Jiangsu Province, China, 2012-2019.","authors":"Yifan Wang, Yue Jiang, Hui Wang, Shuang Liang, Muhammed Lamin Sambou, Mei Wang, Meiqi Yang, Yakubu Salimata, Feifei Xu, Chenjie Li, Xiao Wang, Junpeng Yang, Meng Zhu, Cheng Wang, Guangfu Jin, Hongxia Ma, Honggang Yi, Hongbing Shen, Juncheng Dai","doi":"10.46234/ccdcw2024.258","DOIUrl":"10.46234/ccdcw2024.258","url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>China is rapidly encountering population aging, yet studies on aging are limited by the traditional aging measure: chronological age, particularly in the field of genomics. Several promising aging measures have been proposed, but they lack comparative evaluation.</p><p><strong>What is added by this report?: </strong>PhenoAge was identified as a measure of aging that demonstrated greater applicability in contemporary populations. Based on this, several novel genetic variants were found to enhance the predictive accuracy of aging.</p><p><strong>What are the implications for public health practice?: </strong>These findings might provide new insights into aging and facilitate the development of a practical screening program based on PhenoAge, which aims to promote healthy aging in China.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 49","pages":"1294-1298"},"PeriodicalIF":4.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological Characteristics of Falls from the National Injury Surveillance System - China, 2019-2022. 2019-2022年中国国家伤害监测系统中跌倒的流行病学特征
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-06 DOI: 10.46234/ccdcw2024.256
Siyi Chen, Yuliang Er, Yuan Wang, Leilei Duan, Pengpeng Ye

Introduction: This study describes and analyzes the distribution of fall cases documented in the National Injury Surveillance System (NISS) from 2019 to 2022.

Methods: Fall data from the NISS (2019-2022) were descriptively analyzed by gender and age.

Results: The NISS in China reported 2,324,577 fall cases from 2019 to 2022. Falls mostly happened at home (39.41%). Leisure activities (39.40%) were the most common cause of falls. Among these cases, 45.22% caused bruises, 31.57% lower limb injuries, while a substantial 73.41% constituted mild injuries. Age-related epidemiological patterns of falls revealed distinct trends. Among 0-9-year-olds, falls predominantly occurred at home (56.71%), with high head injury rates, particularly in infants (72.64%). Adolescents (10-19 years old) were prone to falls in school and school-related areas (37.12%) and during sports activities (27.37%). Elderly individuals (>60 years old) experienced higher fracture rates (36.84%) and an age-dependent increase in head injuries and severe harm.

Conclusions: Falls are the most prevalent injury category, exhibiting distinct characteristics across age groups. To address this, tailored public health strategies and interventions are essential, particularly for children, adolescents, and adults aged 60 years and older. Effective early prevention and intervention methods are paramount for these high-risk fall populations.

本研究描述并分析了2019年至2022年国家伤害监测系统(NISS)中记录的跌倒病例的分布。方法:对NISS(2019-2022)的跌倒数据按性别和年龄进行描述性分析。结果:2019年至2022年,中国NISS报告了2324577例跌倒病例。跌倒主要发生在家里(39.41%)。休闲活动(39.40%)是最常见的跌倒原因。其中擦伤占45.22%,下肢损伤占31.57%,轻伤占73.41%。与年龄相关的跌倒流行病学模式显示出明显的趋势。在0-9岁儿童中,跌倒主要发生在家中(56.71%),头部损伤率很高,尤其是婴儿(72.64%)。青少年(10-19岁)在学校及与学校有关的场所(37.12%)和体育活动中(27.37%)容易跌倒。老年人(60岁至60岁)骨折率较高(36.84%),头部损伤和严重伤害的年龄依赖性增加。结论:跌倒是最常见的伤害类型,在不同年龄组中表现出不同的特征。为解决这一问题,有针对性的公共卫生战略和干预措施至关重要,特别是针对儿童、青少年和60岁及以上的成年人。有效的早期预防和干预方法对这些高危跌倒人群至关重要。
{"title":"Epidemiological Characteristics of Falls from the National Injury Surveillance System - China, 2019-2022.","authors":"Siyi Chen, Yuliang Er, Yuan Wang, Leilei Duan, Pengpeng Ye","doi":"10.46234/ccdcw2024.256","DOIUrl":"10.46234/ccdcw2024.256","url":null,"abstract":"<p><strong>Introduction: </strong>This study describes and analyzes the distribution of fall cases documented in the National Injury Surveillance System (NISS) from 2019 to 2022.</p><p><strong>Methods: </strong>Fall data from the NISS (2019-2022) were descriptively analyzed by gender and age.</p><p><strong>Results: </strong>The NISS in China reported 2,324,577 fall cases from 2019 to 2022. Falls mostly happened at home (39.41%). Leisure activities (39.40%) were the most common cause of falls. Among these cases, 45.22% caused bruises, 31.57% lower limb injuries, while a substantial 73.41% constituted mild injuries. Age-related epidemiological patterns of falls revealed distinct trends. Among 0-9-year-olds, falls predominantly occurred at home (56.71%), with high head injury rates, particularly in infants (72.64%). Adolescents (10-19 years old) were prone to falls in school and school-related areas (37.12%) and during sports activities (27.37%). Elderly individuals (>60 years old) experienced higher fracture rates (36.84%) and an age-dependent increase in head injuries and severe harm.</p><p><strong>Conclusions: </strong>Falls are the most prevalent injury category, exhibiting distinct characteristics across age groups. To address this, tailored public health strategies and interventions are essential, particularly for children, adolescents, and adults aged 60 years and older. Effective early prevention and intervention methods are paramount for these high-risk fall populations.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 49","pages":"1283-1288"},"PeriodicalIF":4.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological Analysis of Tuberculosis Infection and Trend Changes - 152 Belt and Road Partner Countries, 2013-2021. 2013-2021年152个“一带一路”伙伴国结核病感染流行病学分析及趋势变化
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-06 DOI: 10.46234/ccdcw2024.257
Rong Du, Xiao Xiao, Jing Chen, Xin Shen, Qi Zhao

What is already known about this topic?: The Belt and Road Initiative promotes increased interactions among participating countries, which concurrently elevates the risk of infectious diseases such as tuberculosis (TB). Since TB infection can significantly contribute to the disease burden, it is crucial to delineate the epidemic status and identify the change trends in TB infection among the countries involved in the initiative.

What is added by this report?: TB infection was prevalent in 152 countries along the Belt and Road initiative. Most of these countries had an infection prevalence between 10% and 30%, among which were 9 countries (5.92%) with a prevalence below 10% and 8 countries (5.26%) with a reported prevalence of 40% and higher. From 2013 to 2021, a notable reduction in TB infection prevalence was observed in 149 countries (98.03%). In contrast, Sri Lanka and the Philippines exhibited an increasing trend, while no significant change was detected in Timor-Leste.

What are the implications for public health practice?: Addressing TB surveillance, prevention, and management, as well as collaboration among these countries, is a proposed key strategy for achieving the global end TB strategy.

关于这个话题我们已经知道了什么?“一带一路”倡议促进了参与国之间的互动,同时也增加了结核病等传染病的风险。由于结核病感染可大大增加疾病负担,因此,在参与该倡议的国家中描述结核病流行状况并确定结核病感染的变化趋势至关重要。这份报告增加了什么内容?结核感染在“一带一路”沿线152个国家普遍存在。这些国家的感染率大多在10% - 30%之间,其中9个国家(5.92%)的感染率低于10%,8个国家(5.26%)的感染率在40%及以上。从2013年至2021年,149个国家(98.03%)的结核病感染流行率显著下降。相比之下,斯里兰卡和菲律宾表现出增加的趋势,而东帝汶没有发现重大变化。这对公共卫生实践有什么影响?解决结核病监测、预防和管理以及这些国家之间的合作问题,是为实现全球终止结核病战略提出的一项关键战略。
{"title":"Epidemiological Analysis of Tuberculosis Infection and Trend Changes - 152 Belt and Road Partner Countries, 2013-2021.","authors":"Rong Du, Xiao Xiao, Jing Chen, Xin Shen, Qi Zhao","doi":"10.46234/ccdcw2024.257","DOIUrl":"10.46234/ccdcw2024.257","url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>The Belt and Road Initiative promotes increased interactions among participating countries, which concurrently elevates the risk of infectious diseases such as tuberculosis (TB). Since TB infection can significantly contribute to the disease burden, it is crucial to delineate the epidemic status and identify the change trends in TB infection among the countries involved in the initiative.</p><p><strong>What is added by this report?: </strong>TB infection was prevalent in 152 countries along the Belt and Road initiative. Most of these countries had an infection prevalence between 10% and 30%, among which were 9 countries (5.92%) with a prevalence below 10% and 8 countries (5.26%) with a reported prevalence of 40% and higher. From 2013 to 2021, a notable reduction in TB infection prevalence was observed in 149 countries (98.03%). In contrast, Sri Lanka and the Philippines exhibited an increasing trend, while no significant change was detected in Timor-Leste.</p><p><strong>What are the implications for public health practice?: </strong>Addressing TB surveillance, prevention, and management, as well as collaboration among these countries, is a proposed key strategy for achieving the global end TB strategy.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 49","pages":"1289-1293"},"PeriodicalIF":4.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of Vaginitis Among Chinese Women Aged 18-74 Years - Five Provinces, China, 2023. 中国18-74岁女性阴道炎负担-中国五省,2023。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-06 DOI: 10.46234/ccdcw2024.259
Zixuan Fan, Chenyang Pei, Jing Ma, Chengdong Xu, Zhenbo Wang, Yuanli Liu, Yuehua Hu

What is already known about this topic?: Vaginitis is a prevalent and treatable gynecological condition in women that is associated with adverse reproductive outcomes, human papillomavirus (HPV) infection, and elevated human immunodeficiency virus (HIV) transmission risk.

What is added by this report?: This study identifies elevated infection risks among women aged 35-54 years, those with three or more pregnancies, and individuals who smoke or consume alcohol, with notably higher prevalence rates in Hubei and Yunnan Provinces. The findings demonstrate that awareness of cervical cancer screening serves as a protective factor, while emphasizing screening's crucial role in early vaginitis detection.

What are the implications for public health practice?: Public health interventions should prioritize women aged 35-54 years, those with multiple pregnancies, and individuals engaging in high-risk behaviors. Enhancing cervical cancer screening awareness and accessibility is essential for improving early detection and management of vaginal infections, thereby reducing reproductive health disparities.

关于这个话题我们已经知道了什么?阴道炎是女性中一种普遍且可治疗的妇科疾病,与不良生殖结果、人乳头瘤病毒(HPV)感染和人类免疫缺陷病毒(HIV)传播风险升高有关。这份报告增加了什么内容?本研究发现,年龄在35-54岁之间的女性、怀孕三次或三次以上的女性以及吸烟或饮酒的女性感染风险较高,其中湖北和云南的患病率明显较高。研究结果表明,意识到宫颈癌筛查是一个保护因素,同时强调筛查在早期发现阴道炎中的关键作用。这对公共卫生实践有什么影响?公共卫生干预应优先考虑35-54岁妇女、多胎妊娠妇女和有高危行为的个体。提高对宫颈癌筛查的认识和可及性对于改善阴道感染的早期发现和管理,从而缩小生殖健康差距至关重要。
{"title":"Burden of Vaginitis Among Chinese Women Aged 18-74 Years - Five Provinces, China, 2023.","authors":"Zixuan Fan, Chenyang Pei, Jing Ma, Chengdong Xu, Zhenbo Wang, Yuanli Liu, Yuehua Hu","doi":"10.46234/ccdcw2024.259","DOIUrl":"10.46234/ccdcw2024.259","url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>Vaginitis is a prevalent and treatable gynecological condition in women that is associated with adverse reproductive outcomes, human papillomavirus (HPV) infection, and elevated human immunodeficiency virus (HIV) transmission risk.</p><p><strong>What is added by this report?: </strong>This study identifies elevated infection risks among women aged 35-54 years, those with three or more pregnancies, and individuals who smoke or consume alcohol, with notably higher prevalence rates in Hubei and Yunnan Provinces. The findings demonstrate that awareness of cervical cancer screening serves as a protective factor, while emphasizing screening's crucial role in early vaginitis detection.</p><p><strong>What are the implications for public health practice?: </strong>Public health interventions should prioritize women aged 35-54 years, those with multiple pregnancies, and individuals engaging in high-risk behaviors. Enhancing cervical cancer screening awareness and accessibility is essential for improving early detection and management of vaginal infections, thereby reducing reproductive health disparities.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 49","pages":"1299-1305"},"PeriodicalIF":4.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National and Regional Molecular Epidemiology of HIV-1 - China, 2004-2023. 2004-2023年中国HIV-1国家和地区分子流行病学。
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-11-29 DOI: 10.46234/ccdcw2024.252
Dong Wang, Yi Feng, Jingjing Hao, Hongping Hu, Fangyuan Li, Jialu Li, Yuhua Ruan, Lingjie Liao, Jing Hu, Chang Song, Yiming Shao, Hui Xing

Introduction: The genetic diversity of human immunodeficiency virus (HIV)-1 subtypes significantly influences the effectiveness of diagnostic tools, antiretroviral therapy (ART), and vaccine development. This study aimed to assess the regional and national prevalence of HIV-1 subtypes and recombinants in China between 2004 and 2023 using pol gene segment analysis.

Methods: We analyzed annual HIV/AIDS reports and pol gene segment sequences from all Chinese provinces between 2004 and 2023. The distribution of HIV-1 subtypes and recombinants across China and within its regions was estimated by multiplying the proportion of each subtype, circulating recombinant form (CRF), and unique recombinant form (URF) in each province by the corresponding number of reported HIV infections.

Results: Analysis of 94,476 pol gene segments from 31 provinces revealed that CRF01_AE strain accounted for 32.1% of HIV-1 infections during 2004-2023, while CRF07_BC lineage represented 39.1%. CRF08_BC strain contributed 9.2%, followed by subtype B (8.7%) and CRF55_01B (2.4%). Other CRFs collectively comprised 6.0% of infections, while URFs and other subtypes accounted for 1.3% and 1.1%, respectively.

Conclusions: The study revealed significant regional variations and temporal changes in the proportions of HIV-1 CRFs, subtypes, and URFs across China, emphasizing the importance of continued surveillance of strain distribution patterns.

人类免疫缺陷病毒(HIV)-1亚型的遗传多样性显著影响诊断工具、抗逆转录病毒治疗(ART)和疫苗开发的有效性。本研究旨在利用pol基因片段分析,评估2004年至2023年间中国HIV-1亚型和重组体的区域和国家流行情况。方法:分析2004 - 2023年中国各省HIV/AIDS年度报告和pol基因片段序列。通过将每个省份中每种亚型、循环重组形式(CRF)和独特重组形式(URF)的比例乘以相应的HIV感染报告数,估计了HIV-1亚型和重组形式在中国及其区域内的分布。结果:对来自31个省份的94,476个pol基因片段的分析显示,2004-2023年,CRF01_AE株占HIV-1感染的32.1%,CRF07_BC株占39.1%。CRF08_BC株占9.2%,其次是B亚型(8.7%)和CRF55_01B(2.4%)。其他crf共占感染的6.0%,而urf和其他亚型分别占1.3%和1.1%。结论:该研究揭示了中国HIV-1 crf、亚型和urf比例的显著区域差异和时间变化,强调了继续监测毒株分布模式的重要性。
{"title":"National and Regional Molecular Epidemiology of HIV-1 - China, 2004-2023.","authors":"Dong Wang, Yi Feng, Jingjing Hao, Hongping Hu, Fangyuan Li, Jialu Li, Yuhua Ruan, Lingjie Liao, Jing Hu, Chang Song, Yiming Shao, Hui Xing","doi":"10.46234/ccdcw2024.252","DOIUrl":"10.46234/ccdcw2024.252","url":null,"abstract":"<p><strong>Introduction: </strong>The genetic diversity of human immunodeficiency virus (HIV)-1 subtypes significantly influences the effectiveness of diagnostic tools, antiretroviral therapy (ART), and vaccine development. This study aimed to assess the regional and national prevalence of HIV-1 subtypes and recombinants in China between 2004 and 2023 using pol gene segment analysis.</p><p><strong>Methods: </strong>We analyzed annual HIV/AIDS reports and pol gene segment sequences from all Chinese provinces between 2004 and 2023. The distribution of HIV-1 subtypes and recombinants across China and within its regions was estimated by multiplying the proportion of each subtype, circulating recombinant form (CRF), and unique recombinant form (URF) in each province by the corresponding number of reported HIV infections.</p><p><strong>Results: </strong>Analysis of 94,476 pol gene segments from 31 provinces revealed that CRF01_AE strain accounted for 32.1% of HIV-1 infections during 2004-2023, while CRF07_BC lineage represented 39.1%. CRF08_BC strain contributed 9.2%, followed by subtype B (8.7%) and CRF55_01B (2.4%). Other CRFs collectively comprised 6.0% of infections, while URFs and other subtypes accounted for 1.3% and 1.1%, respectively.</p><p><strong>Conclusions: </strong>The study revealed significant regional variations and temporal changes in the proportions of HIV-1 CRFs, subtypes, and URFs across China, emphasizing the importance of continued surveillance of strain distribution patterns.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 48","pages":"1257-1263"},"PeriodicalIF":4.3,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the Technical Parameters for Estimating HIV-1 Incidence by Using a Recombinant Antigen-based Capture Enzyme Immunoassay - China. 用重组抗原捕获酶免疫分析法估计HIV-1发病率的技术参数研究
IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-11-29 DOI: 10.46234/ccdcw2024.255
Wenli Liang, Jibao Wang, Hongxia Yan, Xinhui Zhang, Dorjiwangmo, Dongmin Li, Xing Duan, Hao Wu, Yinyin Wang, Li Bai, Jian Sun, Mengjie Han, Yikui Wang, Bin Su, Min Wang, Tashibazong, Wenge Xing, Cui Zhang, Ruijuan Qiao, Maofeng Qiu

Introduction: A novel recombinant antigen-based capture enzyme immunoassay (RAg-CEIA) was optimized and used to determine technical parameters for estimating human immunodeficiency virus type 1 (HIV-1) incidence in China.

Methods: We employed orthogonal experimental design to optimize RAg-CEIA by adjusting raw material dilution ratios. The assay was used to measure normalized optical density (ODn) values in 171 longitudinal plasma specimens from 51 HIV-1 seroconverting individuals, plotted against estimated days post-seroconversion. We determined the optimal ODn threshold value for differentiating recent from long-term infections and calculated the mean duration of recent infection (MDRI) for incidence estimation. The false recent rate (FRR) was determined using 481 HIV-1 antibody-positive specimens with infection durations exceeding twice the MDRI.

Results: Optimal RAg-CEIA parameters were established with a raw material dilution ratio of 1/12 for calibrator preparation and an enzyme conjugate titer of 1:1200. ODn values demonstrated consistent temporal increases across HIV-1 seroconverting individuals, though with notable kinetic heterogeneity in individual responses. The optimal ODn threshold value of 0.8 for distinguishing recent from long-term infections corresponded to an MDRI of 205 days and an FRR of 4.78%.

Conclusions: The optimized RAg-CEIA effectively differentiates recent from long-term HIV-1 infections at the population level, enabling reliable HIV-1 incidence estimation in China.

本文对一种新的重组抗原捕获酶免疫分析法(raga - ceia)进行了优化,并用于确定估计中国人类免疫缺陷病毒1型(HIV-1)发病率的技术参数。方法采用正交试验设计,通过调整原料稀释比,优化拉格- ceia。该方法用于测量51名HIV-1血清转化个体的171份纵向血浆标本的归一化光密度(ODn)值,并与血清转化后的估计天数进行绘图。我们确定了区分近期感染和长期感染的最佳ODn阈值,并计算了近期感染的平均持续时间(MDRI)用于发病率估计。假近期率(FRR)是用感染时间超过MDRI两倍的481例HIV-1抗体阳性标本测定的。结果:以原料稀释比为1/12,酶偶联滴度为1:1200为校准器制备的最佳拉格- ceia参数。ODn值在HIV-1血清转化个体中显示出一致的时间增加,尽管个体反应具有显著的动力学异质性。区分近期感染和长期感染的最佳ODn阈值为0.8,对应于205天的MDRI和4.78%的FRR。结论:优化后的raga - ceia在人群水平上有效地区分了近期和长期的HIV-1感染,从而实现了中国HIV-1发病率的可靠估计。
{"title":"Study on the Technical Parameters for Estimating HIV-1 Incidence by Using a Recombinant Antigen-based Capture Enzyme Immunoassay - China.","authors":"Wenli Liang, Jibao Wang, Hongxia Yan, Xinhui Zhang, Dorjiwangmo, Dongmin Li, Xing Duan, Hao Wu, Yinyin Wang, Li Bai, Jian Sun, Mengjie Han, Yikui Wang, Bin Su, Min Wang, Tashibazong, Wenge Xing, Cui Zhang, Ruijuan Qiao, Maofeng Qiu","doi":"10.46234/ccdcw2024.255","DOIUrl":"10.46234/ccdcw2024.255","url":null,"abstract":"<p><strong>Introduction: </strong>A novel recombinant antigen-based capture enzyme immunoassay (RAg-CEIA) was optimized and used to determine technical parameters for estimating human immunodeficiency virus type 1 (HIV-1) incidence in China.</p><p><strong>Methods: </strong>We employed orthogonal experimental design to optimize RAg-CEIA by adjusting raw material dilution ratios. The assay was used to measure normalized optical density (ODn) values in 171 longitudinal plasma specimens from 51 HIV-1 seroconverting individuals, plotted against estimated days post-seroconversion. We determined the optimal ODn threshold value for differentiating recent from long-term infections and calculated the mean duration of recent infection (MDRI) for incidence estimation. The false recent rate (FRR) was determined using 481 HIV-1 antibody-positive specimens with infection durations exceeding twice the MDRI.</p><p><strong>Results: </strong>Optimal RAg-CEIA parameters were established with a raw material dilution ratio of 1/12 for calibrator preparation and an enzyme conjugate titer of 1:1200. ODn values demonstrated consistent temporal increases across HIV-1 seroconverting individuals, though with notable kinetic heterogeneity in individual responses. The optimal ODn threshold value of 0.8 for distinguishing recent from long-term infections corresponded to an MDRI of 205 days and an FRR of 4.78%.</p><p><strong>Conclusions: </strong>The optimized RAg-CEIA effectively differentiates recent from long-term HIV-1 infections at the population level, enabling reliable HIV-1 incidence estimation in China.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 48","pages":"1278-1282"},"PeriodicalIF":4.3,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国疾病预防控制中心周报
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1